AU2002353775A1 - Lipopeptide stereoisomers, methods for preparing same, and useful intermediates - Google Patents

Lipopeptide stereoisomers, methods for preparing same, and useful intermediates

Info

Publication number
AU2002353775A1
AU2002353775A1 AU2002353775A AU2002353775A AU2002353775A1 AU 2002353775 A1 AU2002353775 A1 AU 2002353775A1 AU 2002353775 A AU2002353775 A AU 2002353775A AU 2002353775 A AU2002353775 A AU 2002353775A AU 2002353775 A1 AU2002353775 A1 AU 2002353775A1
Authority
AU
Australia
Prior art keywords
methods
lipopeptide
stereoisomers
preparing same
useful intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002353775A
Other languages
English (en)
Inventor
Mario Bouchard
John Finn
Michael Jung
Michael Morytko
Yanzhi Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cubist Pharmaceuticals LLC
Original Assignee
Cubist Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharmaceuticals LLC filed Critical Cubist Pharmaceuticals LLC
Publication of AU2002353775A1 publication Critical patent/AU2002353775A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002353775A 2001-08-06 2002-08-06 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates Abandoned AU2002353775A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31031301P 2001-08-06 2001-08-06
US60/310,313 2001-08-06
PCT/US2002/025106 WO2003017924A2 (en) 2001-08-06 2002-08-06 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates

Publications (1)

Publication Number Publication Date
AU2002353775A1 true AU2002353775A1 (en) 2003-03-10

Family

ID=23201948

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002353775A Abandoned AU2002353775A1 (en) 2001-08-06 2002-08-06 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates

Country Status (15)

Country Link
US (5) US20030083240A1 (cg-RX-API-DMAC7.html)
EP (2) EP1423137B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005531486A (cg-RX-API-DMAC7.html)
KR (1) KR20040022233A (cg-RX-API-DMAC7.html)
CN (1) CN100352836C (cg-RX-API-DMAC7.html)
AT (1) ATE430160T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002353775A1 (cg-RX-API-DMAC7.html)
BR (1) BR0211761A (cg-RX-API-DMAC7.html)
CA (2) CA2456761A1 (cg-RX-API-DMAC7.html)
DE (1) DE60232158D1 (cg-RX-API-DMAC7.html)
IL (1) IL160171A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ531493A (cg-RX-API-DMAC7.html)
RU (1) RU2348647C2 (cg-RX-API-DMAC7.html)
WO (2) WO2003017924A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200400928B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003017924A2 (en) * 2001-08-06 2003-03-06 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
US6767718B2 (en) * 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
RU2007121705A (ru) * 2004-11-12 2008-12-20 Кьюбист Фармасьютикалз Антиинфекционные липопептиды
KR20070089996A (ko) * 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법
NZ580951A (en) * 2005-04-29 2011-06-30 Cubist Pharm Inc Therapeutic compositions
CN102014897B (zh) * 2008-04-21 2015-08-05 西格纳姆生物科学公司 化合物、组合物和其制备方法
NZ594019A (en) 2008-12-22 2013-08-30 Cubist Pharm Inc Novel antibacterial agents for the treatment of gram positive infections
WO2010075416A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN101899094B (zh) * 2009-06-01 2012-11-21 安徽丰原发酵技术工程研究有限公司 一种高纯达托霉素的制备方法
KR101013755B1 (ko) * 2010-02-02 2011-02-14 주식회사 삼광산전 정출력용 엘이디모듈 전원공급 컨버터
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN102351775B (zh) * 2011-09-14 2013-10-09 佛山普正医药科技有限公司 一种左旋5-羟基色氨酸的制备方法
WO2013059610A1 (en) 2011-10-20 2013-04-25 Trius Therapeutics, Inc. Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
CA2890933C (en) * 2012-12-03 2021-06-08 Novobiotic Pharmaceuticals, Llc Novel depsipeptide and uses thereof
JP6634197B2 (ja) * 2013-05-08 2020-01-22 株式会社ゲノム創薬研究所 固相レジンを用いた環状ペプチド化合物の製造方法
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
KR101671325B1 (ko) * 2015-01-09 2016-11-02 한국생명공학연구원 신규한 고리형 뎁시펩타이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 항균용 약학적 조성물
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE32333E (en) * 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
US4800157A (en) * 1985-09-09 1989-01-24 Eli Lilly And Company Process for producing the A-21978C antibiotics
US4874843A (en) * 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US4994270A (en) * 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5028590A (en) * 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
IL98349A (en) 1990-06-07 1995-05-26 Lilly Co Eli Diphylase lipopeptide
CA2131389A1 (en) * 1992-03-02 1993-09-16 John M. Maraganore Thrombin receptor antagonists
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
ATE544851T1 (de) 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
US5958728A (en) * 1996-11-18 1999-09-28 Novo Nordiskbiotech, Inc. Methods for producing polypeptides in mutants of bacillus cells
US20010041346A1 (en) 1999-07-14 2001-11-15 Michael E. Mendelsohn Method for assaying compounds affecting smooth muscle contractile state
BR0017026A (pt) 1999-12-15 2003-01-07 Cubist Pharm Inc Lipeptìdeos como agentes antibacterianos
IL150224A0 (en) 1999-12-15 2002-12-01 Cubist Pharm Inc Lipopeptides and pharmaceutical compositions containing the same
CN1423656A (zh) 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的脂肽
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6750199B2 (en) * 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
WO2003017924A2 (en) * 2001-08-06 2003-03-06 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates

Also Published As

Publication number Publication date
US7335726B2 (en) 2008-02-26
CA2456761A1 (en) 2003-02-20
ZA200400928B (en) 2005-05-04
WO2003014147A1 (en) 2003-02-20
WO2003017924A2 (en) 2003-03-06
EP1423414A4 (en) 2005-11-30
IL160171A0 (en) 2004-07-25
JP2005531486A (ja) 2005-10-20
CN100352836C (zh) 2007-12-05
EP1423137B1 (en) 2009-04-29
WO2003017924A3 (en) 2004-03-04
US20080119395A1 (en) 2008-05-22
US20030083240A1 (en) 2003-05-01
CN1551887A (zh) 2004-12-01
RU2004106630A (ru) 2005-06-27
US20060194714A1 (en) 2006-08-31
EP1423414A1 (en) 2004-06-02
EP1423137A4 (en) 2005-11-30
US20060223983A1 (en) 2006-10-05
KR20040022233A (ko) 2004-03-11
US20030096948A1 (en) 2003-05-22
US7262268B2 (en) 2007-08-28
EP1423137A2 (en) 2004-06-02
NZ531493A (en) 2006-03-31
RU2348647C2 (ru) 2009-03-10
BR0211761A (pt) 2007-01-09
ATE430160T1 (de) 2009-05-15
CA2456323A1 (en) 2003-03-06
DE60232158D1 (de) 2009-06-10

Similar Documents

Publication Publication Date Title
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
WO2001044271A3 (en) Daptomycin analogs and their use as antibacterial agents
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
AU2002239344A1 (en) Pyrazolopyridines
DE602004021472D1 (en) Pyrimiidinverbindungen
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
AU2003228770A1 (en) Substituted pyrazolopyrimidines
PL366198A1 (en) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA04004498A (es) Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion.
SE0300119D0 (sv) Novel compounds
DE60112330D1 (en) Pyrazolopyridinderivate
MXPA04001646A (es) Composicion oftalmica que comprende ascomicina.
PL374080A1 (en) Processes for the preparation of fibrinogen
AUPP589598A0 (en) Novel peptides
TW200604197A (en) New compounds
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
AU2001289714A1 (en) Benzofuran derivatives and their use as antibacterial agents
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
MXPA05013012A (es) Formulaciones blanqueadoras fluorescentes estables al almacenamiento.
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA04005151A (es) Compuestos terapeuticos.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase